ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for monitor Customisable watchlists with full streaming quotes from leading exchanges, such as LSE, NASDAQ, NYSE, AMEX, Bovespa, BIT and more.

POLB Poolbeg Pharma Plc

7.65
0.05 (0.66%)
Last Updated: 08:19:14
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Poolbeg Pharma Plc LSE:POLB London Ordinary Share GB00BKPG7Z60 ORD 0.02P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.05 0.66% 7.65 7.60 7.70 7.70 7.65 7.70 223,279 08:19:14
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
Coml Physical, Biologcl Resh 0 -3.93M -0.0079 -9.68 38M
Poolbeg Pharma Plc is listed in the Coml Physical, Biologcl Resh sector of the London Stock Exchange with ticker POLB. The last closing price for Poolbeg Pharma was 7.60p. Over the last year, Poolbeg Pharma shares have traded in a share price range of 7.15p to 15.70p.

Poolbeg Pharma currently has 500,000,000 shares in issue. The market capitalisation of Poolbeg Pharma is £38 million. Poolbeg Pharma has a price to earnings ratio (PE ratio) of -9.68.

Poolbeg Pharma Share Discussion Threads

Showing 3701 to 3721 of 3750 messages
Chat Pages: 150  149  148  147  146  145  144  143  142  141  140  139  Older
DateSubjectAuthorDiscuss
08/11/2024
13:53
And Owenski do not let the Telegram group resident squealer put you off either. Always pops up when a price declines but disappears when it goes up. Of course also highlights imaginary trades as well. Everyone on here has their reasons to hold or sell they are just not so transparent with it
inaminute
06/11/2024
20:23
How's that faked news??;)))
baldrick1
06/11/2024
15:09
Let's hope they can detach themselves from the concurrent drinks long enough to read this blurb amongst many. At least they can use the same board as for the Oncology bash not so long ago.
peterrr3
06/11/2024
13:24
Another balanced analysis as usual. No wonder no one takes you seriously
inaminute
06/11/2024
09:20
Are they still touring the bazaars trying to flog their P38 dud. Is Jeremy still very excited over everything and anything.

So, the second hand car salesman isn't drumming up enough buyers in the UK for this story stock and is going to try to mug US lemmings, good luck with that.

owenski
06/11/2024
09:20
https://www.londonstockexchange.com/news-article/POLB/polb-001-data-to-be-presented-at-ash/16750419Poolbeg will be presenting POLB 001 pre-clinical study data at the prestigious 66th American Society of Hematology (ASH) annual meeting in San Diego next month.The ASH annual meeting and exposition is the world's leading conference on hematological malignancies (blood cancers) and brings industry and academic across the globe to showcase scientific discoveries in clinical care.Poolbeg's poster will share insights into the results obtained from our POLB 001 in vivo study, a mouse model of immunotherapy-induced CRS. This data underscores the potential impact of our innovative approach to preventing cancer immunotherapy-induced CRS.
burtond1
06/11/2024
09:15
Hey it'll be hard to find any investor seeing that POLB001 is still pre clinical as it says in the press release.
Reversing in SPACs has been Suicide for shares over the last few years.
Shareholders have lost 2/3's (and more)of their initial investment..Look it up

chica1
06/11/2024
09:13
You do know the trail for POLB001 will be paid for by the pharmas who are wanting to use it? As for the oral tableting the cost of that has been budgeted for a long time and is miniscule. 50 subjects come in one day at a time pop a pill and come in next day to get a blood test to check the drug is in the bloodstream.
Going to the NASDAQ has got the US fundraisers excited I expect as normally a listing there involves a fundraise however POLB is reversing into a SPAC so not going the normal route.

pogue
06/11/2024
09:02
Pogue I never said fund raise to keep the company afloat, but raise to do any of the trials they need to do and there will be nothing left if they buy a stray orphan drug to sell. You can keep the lights on and a bit of lab work but not much more with the current cash. CEO hasn't been doing the investor rounds in the US for nothing, no pharma there. Every second person liking the socials is in the fund raising game, everyone with the off chance of lining something up is being tapped.I'll do well as I'm now free carried and hope they can cut a good deal, but am a realist about any subsequent dilution that will result.
peterrr3
06/11/2024
08:08
However there is no negative news and no fundraise which you have been insisting is necessary to keep the company afloat.
Will be on NASDAQ by Xmas hopefully and get some intelligent buyers who recognise the multibag potential here.

pogue
04/11/2024
11:42
At 8.78p;)))
baldrick1
04/11/2024
11:41
He's gone ;))
baldrick1
04/11/2024
11:03
I feel a significant faked news is imminent with this rise. Aiming to sell at.085p;)
baldrick1
02/11/2024
17:34
At least you are consistent. A moron on the Hvo board and a moron here.
inaminute
30/10/2024
11:37
Don't worry Baldrick, the socials are working overtime. They have roped in everyone CF has ever met to like them. KPMG now stepping up, so maybe, just maybe there may be something there. They only usually like things that generate fees.
peterrr3
29/10/2024
15:54
Urgently in need of faked news to stem the descending share price chart.Cash must be well under 10 million now, imho
baldrick1
28/10/2024
19:07
Don't worry, the telegram group are buying more. They don't sell, only buy. NASDAQ before Christmas and Cathal says the share price will be multiples by end of year......not sure which one though
malcolmz1
28/10/2024
15:45
7p this week ???
baldrick1
24/10/2024
13:26
He's a good business man. Everyone just neees learn to sell when he starts ramping.
malcolmz1
24/10/2024
07:27
Baldrick they RNSd the OTC ages ago. No real bearing on anything. CF nominated for Business person of the year, lol, equally no bearing on anything, but maybe KPMG wants to screw some fees out of him later.
peterrr3
23/10/2024
18:11
Could still go down to 5-7p to the end of the month
baldrick1
Chat Pages: 150  149  148  147  146  145  144  143  142  141  140  139  Older

Your Recent History

Delayed Upgrade Clock